Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Amneal Pharmaceuticals, Inc. | Co-CEO, Director | Class A Common Stock | 24.8M | $102M | $4.13 | Nov 7, 2023 | By Family Trusts |
Amneal Pharmaceuticals, Inc. | Co-CEO, Director | Performance-Based Restricted Stock Units | 1.33M | $7.29M | $5.47 | Mar 4, 2024 | Direct |
Amneal Pharmaceuticals, Inc. | Co-CEO, Director | Class A Common Stock | 513K | $2.12M | $4.13 | Nov 7, 2023 | Direct |
Amneal Pharmaceuticals, Inc. | Co-CEO, Director | Restricted Stock Units | 370K | $2.03M | $5.47 | Mar 4, 2024 | Direct |
Amneal Pharmaceuticals, Inc. | Co-CEO, Director | Class B Common Stock and Common Units | 0 | $4.13 | Nov 7, 2023 | By Family Trusts |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
AMRX | Amneal Pharmaceuticals, Inc. | Mar 4, 2024 | 2 | $0 | 4 | Mar 6, 2024 | Co-CEO, Director |
AMRX | Amneal Pharmaceuticals, Inc. | Nov 7, 2023 | 2 | $0 | 4 | Nov 8, 2023 | Co-CEO, Director |
AMRX | Amneal Pharmaceuticals, Inc. | Mar 3, 2023 | 1 | $0 | 4 | Mar 7, 2023 | Co-CEO, Director |
AMRX | Amneal Pharmaceuticals, Inc. | Mar 3, 2022 | 1 | $0 | 4 | Mar 3, 2022 | Co-CEO, Director |
AMRX | Amneal Pharmaceuticals, Inc. | Dec 15, 2021 | 2 | $626K | 4 | Dec 17, 2021 | Co-CEO, Director |